Mitomycin derivatives having reduced bone marrow toxicity, proce

Details Mitomycin derivatives having reduced bone marrow toxicity, proce Mitomycin derivatives having reduced bone marrow toxicity, proce

1990-12-03

1992-02-25

Griffin, Ronald W.

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

536 174, 536 22, 536 43, 514908, 548422, A61K 3140, A61K 2100, C07D48714

Patent

active

050915231

ABSTRACT:
The invention relates to certain derivatives of mitomycins A and C and the use thereof to treat bacterial infections and to supress the growth of cancer cells. The invention also relates to processes for the preparation of the mitomycin derivatives of the invention.

REFERENCES:
patent: 3226393 (1965-12-01), Meyer et al.
patent: 3367945 (1968-02-01), Matsui et al.
patent: 3450705 (1969-06-01), Matsui et al.
patent: 4021449 (1977-05-01), Fujimoto et al.
patent: 4268676 (1981-05-01), Remers
patent: 4395558 (1983-07-01), Kasai et al.
patent: 4720543 (1988-01-01), McPherson et al.
patent: 4746746 (1988-05-01), Remers
patent: 4771068 (1988-09-01), Kasai et al.
patent: 4791130 (1988-12-01), Kuroda et al.
patent: 4814445 (1989-03-01), Vyas et al.
patent: 4820824 (1989-04-01), Kono et al.
Kinoshita, S. et al., J. Med. Chem. 14:103-112 (1971).
Anderson, T. et al., Cancer Res., 35:761-765 (1975).
Iyengar, B. et al., J. Med. Chem., 24:975-981 (1981).
Iyengar, B. et al., J. Med. Chem., 26:16-20 (1983).
Iyengar, B. et al., J. Med. Chem., 26:1453-1457 (1983).
Iyengar, B. et al., J. Med. Chem., 29:1864-1868 (1986).
Matsui, M. et al., Chem. Abstr., 69:8138 (Abstr. 86986k) (1968).
Oboshi, S., et al., GANN, 58:315-321 (1967).
Sami, S. M. et al., J. Med. Chem., 27:701-708 (1984).
Schein, P. S. et al., Cancer Res., 47:696-699 (1987).
Talebian et al., Proc. AACR, 28:Abstr. 1025 (1987).
Usubuchi, I., et al., GANN, 58:307-313 (1967).

Affiliated with

Also associated with

Rating

Mitomycin derivatives having reduced bone marrow toxicity, proce does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mitomycin derivatives having reduced bone marrow toxicity, proce, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mitomycin derivatives having reduced bone marrow toxicity, proce will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1894109